What is Cera?
Founded in 2016 and headquartered in London, Cera operates at the intersection of technology and social care. The company provides a comprehensive platform that facilitates in-home health services, effectively bridging the gap between patients and professional caregivers. By integrating data-driven insights with logistical efficiency, Cera enables patients to receive high-quality medical attention within the comfort of their own homes. This model not only alleviates pressure on hospital systems but also enhances patient outcomes through personalized, continuous monitoring and care delivery. As the demand for decentralized healthcare solutions rises, Cera remains at the forefront of the industry, utilizing its proprietary technology to streamline care coordination and improve operational transparency for healthcare providers and families alike.
How much funding has Cera raised?
Cera has raised a total of $327M across 2 funding rounds:
Series A
$7M
Other Financing Round
$320M
Series A (2020): $7M with participation from JJDC , Inc., Asabys Partners Company, and Atlantic Labs
Other Financing Round (2022): $320M led by Schroders Capital, KairosHQ, and Jane Street Capital
Key Investors in Cera
Schroders Capital
A global investment management firm that provides access to private equity and venture capital, focusing on long-term value creation across diverse sectors.
Atlantic Labs
A Berlin-based venture capital firm specializing in early-stage investments in digital health and technology-driven startups.
JJDC, Inc.
The strategic venture capital arm of Johnson & Johnson, focused on investing in innovative healthcare companies that align with their medical device and pharmaceutical expertise.
What's next for Cera?
With this major strategic investment, Cera is well-positioned to scale its operations and deepen its technological capabilities. The company is expected to focus on expanding its geographic footprint and enhancing its AI-driven care management platform to better predict patient needs and optimize resource allocation. As Cera moves into this next phase of maturity, the focus will likely shift toward integrating more advanced diagnostic tools and strengthening partnerships with public and private health systems. This capital injection provides the necessary runway to innovate within the home-care sector, ensuring that Cera remains a leader in the digital transformation of health services while maintaining its commitment to patient-centric care models.
See full Cera company page
